SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092415
Filing Date
2020-08-10
Accepted
2020-08-10 08:00:46
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020417d1_10q.htm 10-Q 713610
2 EXHIBIT 31.1 tm2020417d1_ex31-1.htm EX-31.1 7333
3 EXHIBIT 31.2 tm2020417d1_ex31-2.htm EX-31.2 7282
4 EXHIBIT 32.1 tm2020417d1_ex32-1.htm EX-32.1 3886
5 EXHIBIT 32.2 tm2020417d1_ex32-2.htm EX-32.2 3787
  Complete submission text file 0001104659-20-092415.txt   4417621

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20200630.xml EX-101.INS 877910
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20200630.xsd EX-101.SCH 47662
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20200630_cal.xml EX-101.CAL 32660
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20200630_def.xml EX-101.DEF 162861
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20200630_lab.xml EX-101.LAB 355185
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20200630_pre.xml EX-101.PRE 292708
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 201087170
SIC: 2834 Pharmaceutical Preparations